-
Oncologists on the move
The following oncologists joined new practices, received new appointments or left roles in the last few weeks: -
Mount Sinai Medical Center to build cancer center in Miami Beach
Mount Sinai Medical Center will launch a cancer center on its main campus in Miami Beach, South Florida Hospital News reported March 7. -
Entire North Carolina cancer center board resigns after director's removal
A 15-member external advisory board for the Atrium Health Wake Forest Baptist Comprehensive Cancer Center in Winston-Salem, N.C., resigned following the unexpected removal of the center's director, the Winston-Salem Journal reported March 6. -
Women face more adverse events from targeted, immune cancer therapies than men, study finds
A study examining differences between men and women receiving immune or targeted cancer therapies found that women faced more adverse events than men, just as they face more adverse events with chemotherapy, according to the Journal of Clinical Oncology. -
Gene driving breast cancer metastasis discovered at Yale
Yale researchers discovered that the epigenetic regulator gene cat eye syndrome chromosome region candidate 2, or CECR2, is responsible for driving breast cancer metastasis. -
Researchers' warnings about 'wonder drug' top oncology stories for February
News about potential negative consequences when prescribing metformin for cancer patients was Becker's most-read oncology story in February. -
Cleveland Clinic Florida cancer center welcomes oncologist
Anatoly Nikolaev, MD, PhD, has joined the Cleveland Clinic Weston (Fla.) Maroone Cancer Center. -
Survey investigates toll of cancer care crowdfunding on survivors
The financial relief of medical crowdfunding is often accompanied by feelings of shame in asking for help, a study published in the Journal of Cancer Survivorship suggests. -
UNC Rex opens new cancer center
Raleigh, N.C.-based UNC Rex Healthcare opened a new cancer center March 1. -
1 in 7 breast cancer cases overdiagnosed, Duke study finds
About 1 in 7 breast cancer cases are overdiagnosed, a study published March 1 in the Annals of Internal Medicine found. -
FDA approves new CAR-T cell therapy for multiple myeloma
The FDA approved carvykti, a new customized, cell-based treatment from Johnson & Johnson, for the treatment of multiple myeloma, Johnson & Johnson said Feb. 28. -
Vanderbilt-Ingram Cancer Center names director
Vanderbilt-Ingram Cancer Center in Nashville, Tenn., has selected Ben Ho Park, MD, PhD, as its new director. -
Yale Cancer Center names Conclave award winners
Yale Cancer Center named its annual Conclave awardees in honor of their outstanding contributions to cancer care and research. -
'Wonder drug' metformin not a treatment for all cancer types, researchers caution
Metformin, a drug traditionally prescribed for diabetes but recently used in clinical settings as a cancer treatment, shows "great promise" but can have negative consequences in the treatment of some cancer types, researchers at the University of Waterloo in Canada said Feb. 28. -
UC San Diego Health using sound waves as alternative prostate cancer treatment
Researchers at the University of California San Diego Health are the first in the county to employ high-intensity, focused ultrasound as a minimally invasive prostate cancer treatment, the system said Feb. 24. -
4 recent moves from the American Cancer Society
Here are four announcements from the American Cancer Society reported by Becker's since Feb. 11: -
4 schools share $16M to build cancer equity research centers
The American Cancer Society awarded over $16 million in grants to establish cancer health equity research centers at minority-serving institutions of higher learning across the country, the organization said Feb. 24. -
Hoag selects melanoma program director
Newport Beach, Calif.-based Hoag Memorial Hospital Presbyterian has selected Thomas Wang, MD, PhD, to serve as medical director of its melanoma/advanced skin cancer program. -
City of Hope receives $4.9M stem cell research grant
Los Angeles-based City of Hope was awarded a $4.9 million grant for its department of stem cell biology and regenerative medicine, the cancer research group said Feb. 22. -
Atlantic Health System taps new hematology director
Morristown, N.J.-based Atlantic Health System named Mohamad Cherry, MD, medical director of its hematology and cellular therapy programs, it said Feb. 23.
Page 49 of 50